ORKA Price / Book | Oruka Therapeutics, Inc.

Oruka Therapeutics, Inc. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

Oruka Therapeutics, Inc. price/book ratio for the quarter ending 2026-06-30 was 5.22, a 327.62% increase year-over-year.
Oruka Therapeutics, Inc. price/book ratio for the quarter ending 2026-03-31 was 5.06, a 380.31% increase year-over-year.
Oruka Therapeutics, Inc. price/book ratio for the quarter ending 2025-12-31 was 3.13, a 64.81% increase year-over-year.
Oruka Therapeutics, Inc. price/book ratio for the quarter ending 2025-09-30 was 1.91, a 23.83% decline year-over-year.
Oruka Therapeutics, Inc. price/book ratio for fiscal 2026 was 5.22.
Oruka Therapeutics, Inc. price/book ratio for fiscal 2025 was 3.13, a 64.81% increase from fiscal 2024.
Oruka Therapeutics, Inc. price/book ratio for fiscal 2024 was 1.9, a 76.23% decline from fiscal 2023.
Oruka Therapeutics, Inc. price/book ratio for fiscal 2023 was 7.99, a 18.74% decline from fiscal 2022.

Available history: 2010-12-31 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	5.22	$5.81B	$1.11B
2026-03-31	5.06	$2.46B	$486.72M
2025-12-31	3.13	$1.48B	$471.93M
2025-09-30	1.91	$928.98M	$486.79M
2025-06-30	1.22	$419.26M	$343.64M
2025-03-31	1.05	$384.14M	$364.73M
2024-12-31	1.9	$725.97M	$382.22M
2024-09-30	2.51	$857.81M	$342.37M
2024-06-30	-23.01	$666.75M	-$28.98M
2024-03-31	-43.39	$306.26M	-$7.06M
2024-02-06	61,017.36	$61.02M	$1,000.00
2024-02-05	278,421.96	$278.42M	$1,000.00
2023-12-31	7.99	$295.82M	$37.02M
2023-09-30	9.15	$347.57M	$37.97M
2023-06-30	8.95	$351.03M	$39.24M
2023-03-31	8.49	$344.11M	$40.53M
2022-12-31	9.83	$409.82M	$41.67M
2022-09-30	8.34	$356.22M	$42.73M
2022-06-30	9.58	$430.58M	$44.96M
2022-03-31	8.3	$397.72M	$47.94M
2021-12-31	7.28	$371.78M	$51.04M
2021-09-30	9.04	$511.85M	$56.6M
2021-06-30	9.86	$603.5M	$61.21M
2021-03-31	9.58	$631.16M	$65.91M
2020-12-31	9.88	$459.46M	$46.52M
2020-09-30	9.76	$492.51M	$50.46M
2020-06-30	17.48	$180.14M	$10.31M
2020-03-31	8.46	$53.37M	$6.31M
2019-12-31	14.35	$109.23M	$7.61M
2019-09-30	11.63	$102.34M	$8.8M
2019-06-30	13.91	$127.86M	$9.19M
2019-03-31	12	$87.82M	$7.32M
2018-12-31	9.14	$55.14M	$6.03M
2018-09-30	225.68	$1.68B	$7.46M
2018-06-30	187.18	$1.68B	$9M
2018-03-31	135.95	$1.5B	$11.05M
2017-12-31	334.17	$3.43B	$10.28M
2017-09-30	203.38	$2.92B	$14.35M
2017-06-30	355.63	$5.24B	$14.75M
2017-03-31	280.13	$5.05B	$18.04M
2016-12-31	251.92	$5.59B	$22.19M
2016-09-30	209.62	$5.55B	$26.48M
2016-06-30	183.85	$5.68B	$30.89M
2016-03-31	196.28	$6.79B	$34.58M
2015-12-31	238.8	$9.09B	$38.07M
2015-09-30	235.94	$9.7B	$41.09M
2015-06-30	2,512.16	$109.93B	$43.76M
2015-03-31	2,087.99	$25.32B	$12.13M
2014-12-31	294.42	$4.34B	$14.74M
2014-09-30	2,304.68	$39.64B	$17.2M
2014-06-30	2,400.59	$46.38B	$19.32M
2014-03-31	2,742.8	$59.06B	$21.53M
2013-12-31	2,557.21	$39.84B	$15.58M
2013-09-30	1,737.83	$31.92B	$18.37M
2013-06-30	983	$19.69B	$20.03M
2013-03-31	3,462.23	$11.46B	$3.31M
2012-12-31	3,154.82	$9.17B	$2.91M
2012-09-30	14,615.92	$46.42B	$3.18M
2012-06-30	16,139.82	$53.05B	$3.29M
2012-03-31	23,089.3	$100.58B	$4.36M
2011-12-31	3,213.66	$18.42B	$5.73M
2011-09-30	18,641.43	$106.85B	$5.73M
2011-06-30	20,356.74	$153.59B	$7.55M
2010-12-31	37,522.62	$254.07B	$6.77M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	5.22	$5.81B	$1.11B
2025-12-31	3.13	$1.48B	$471.93M
2024-12-31	1.9	$725.97M	$382.22M
2023-12-31	7.99	$295.82M	$37.02M
2022-12-31	9.83	$409.82M	$41.67M
2021-12-31	7.28	$371.78M	$51.04M
2020-12-31	9.88	$459.46M	$46.52M
2019-12-31	14.35	$109.23M	$7.61M
2018-12-31	9.14	$55.14M	$6.03M
2017-12-31	334.17	$3.43B	$10.28M
2016-12-31	251.92	$5.59B	$22.19M
2015-12-31	238.8	$9.09B	$38.07M
2014-12-31	294.42	$4.34B	$14.74M
2013-12-31	2,557.21	$39.84B	$15.58M
2012-12-31	3,154.82	$9.17B	$2.91M
2011-12-31	3,213.66	$18.42B	$5.73M
2010-12-31	37,522.62	$254.07B	$6.77M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Travere Therapeutics, Inc. (TVTX)	United States	$5.712B	-123.10
Mirum Pharmaceuticals, Inc. (MIRM)	United States	$5.798B	-8.81
Cogent Biosciences, Inc. (COGT)	United States	$5.450B	-17.61
Gossamer Bio, Inc. (GOSS)	United States	$5.355B	-0.65
PTC THERAPEUTICS, INC. (PTCT)	United States	$5.199B	-177.07
Dianthus Therapeutics, Inc. /DE/ (DNTH)	United States	$5.082B	-27.79
Erasca, Inc. (ERAS)	United States	$5.073B	-19.96
Amneal Pharmaceuticals, Inc. (AMRX)		$6.326B	25.62
Liquidia Corp (LQDA)	United States	$6.347B	51.23
Veradermics, Inc (MANE)	United States	$4.839B